Decades of research by the world’s most respected cancer scientists and physicians consistently reveal one conclusion:
This fact led Anpac Bio’s Co-Founders, Dr. Chris Yu and Dr. Herbert Yu, to ask the question that ultimately launched the company:
Achieving that goal became the Anpac Bio’s Co-Founders’ quest. They began breaking the problem apart—drawing on expertise in:
- Cancer research
- Surface science
- Material science
- Engineering and manufacturing
Together they founded Anpac Bio-Medical Science Co., Ltd. in 2008, bringing together a multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts. Their unique, cross-disciplinary approach combines numerous fields of science, medicine and engineering to achieve vastly superior early cancer screening and detection technology.